Rounding Results for Comparison with Specification - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Rounding Results for Comparison with Specification
The mysteries of rounding are exposed.


Pharmaceutical Technology
Volume 37, Issue 4, pp. 122-124

Three rules for rounding The best explanation of unbiased rounding is in a 1947 textbook written by the statistical research group of Columbia University (2). The senior editor, Churchill Eisenhart from the (then) National Bureau of Standards, was one of the most influential statisticians of his era.

Here are the three rules: Rule 1: If the last digit to be dropped is less than 5, the last digit retained shall be left unchanged.

Rule 2: If the last digit to be dropped is greater than 5, or is 5 followed by digits greater than 0, the last digit retained shall be increased by 1.

Rule 3: If the last digit to be dropped is 5 alone or a 5 followed by 0 only, the last digit retained shall be rounded to the nearest even number.


Figure 1: Decision tree for an unbiased rounding process.
It is usually easier to see how such a rule works if you draw it in a decision tree as shown in Figure 1. In this figure, we designate the digit or figure to be rounded by X, the digit or figure to be dropped by Y, and the difference between the truncated value and the full figure value by Z. Based upon the values of X, Y, and Z, we can arrive at the correct unbiased rounding decision.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Pharmaceutical Technology,
Click here